Invesaro

Stocks Health care PLRZ

NASDAQ · Health care

Polyrizon Ltd. (PLRZ)

It posted a net loss of $3.3M. In fiscal 2025 capital spending exceeded operating cash flow by $4.5M. At December 31, 2025 it held $1.3M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer, amended) (20-F/A) filed on March 27, 2026.

Free, no password. An email when PLRZ files with the SEC.

Price
$11.02
+0.80% on the day · November 11, 2026
52-week range $2.88 to $18.20
Market cap
$20.6M

Key facts about Polyrizon Ltd.

Net worth
Polyrizon Ltd. has a market value (market cap) of $20.6M at the latest share price, and shareholders' equity of $21M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Cash flow
In fiscal 2025 operations used $4.5M of cash.
Latest report
The latest periodic report (annual report (foreign issuer, amended), 20-F/A) was filed with the SEC on March 27, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Polyrizon Ltd. does

Polyrizon Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PLRZ.

Revenue and profit by year

Net income
FY22: -$779K -$779K FY22FY24: -$600K -$600K FY24FY24: -$1.5M -$1.5M FY24FY25: -$3.3M -$3.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$6.2M-$3.3M$4.90-$4.5M
2024n/a-$1.3M-$1.5M$805.20n/a
2024n/a-$635K-$600K$494.40n/a
2022n/a-$895K-$779K$988.80-$1.1M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Polyrizon Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 5, 2026
  2. September 28, 2026
  3. September 28, 2026
  4. September 18, 2026
  5. September 4, 2026
  6. September 4, 2026
  7. August 20, 2026
  8. August 14, 2026
  9. July 13, 2026
  10. July 2, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on April 1, 2026. Insider transactions on SEC

Insider trades

What the people running Polyrizon Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
March 31, 2026 Adler OzDirector Sold 3,292 $12.05 $39.7K Form 4
March 31, 2026 Carmel LironDirector Sold 942 $12.36 $11.6K Form 4
March 31, 2026 Izraeli TomerChief Executive Officer, Director Sold 500 $11.85 $5.9K Form 4
March 30, 2026 Turgeman TidharChief Technology Officer, Director Sold 2,917 $10.90 $31.8K Form 4
March 30, 2026 Izraeli TomerChief Executive Officer, Director Sold 3,900 $10.90 $42.5K Form 4
March 30, 2026 Carmel LironDirector Sold 100 $11.00 $1.1K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PLRZ

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
MMCAP International Inc. SPC13G, passive with 1 related filers 9.6% 199,470 August 14, 2026
Tomer Izraeli13G, passive 5.46% 229,252 March 5, 2025

Latest filings below 5%: Eli Zamir 0% (March 16, 2026); L.I.A. Pure Capital Ltd. 0% (March 9, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

4 insiders reported holding 72,007 shares in total, about $793.3K at the last price.

HolderSharesAs of
Izraeli TomerChief Executive Officer, Director 31,512 March 31, 2026
Adler OzDirector 19,850 March 31, 2026
Turgeman TidharChief Technology Officer, Director 17,518 March 30, 2026
Carmel LironDirector 3,127 March 31, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PLRZ

What does Polyrizon Ltd. do?

Polyrizon Ltd. is a company in the Health care sector, listed on NASDAQ as PLRZ. Its shares trade on NASDAQ under the ticker PLRZ.

What is Polyrizon Ltd.'s net worth?

Polyrizon Ltd. has a market value (market cap) of $20.6M at the latest share price, and shareholders' equity of $21M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Polyrizon Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $3.3M.

When did Polyrizon Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer, amended) (20-F/A) filed on March 27, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from October 5, 2026.

Similar companies

Compare PLRZ with

Compare PLRZ with any company

Follow PLRZ

Get an email when Polyrizon Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when PLRZ files with the SEC.

Where the numbers come from

Financial figures are the values Polyrizon Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.